- Key Figures 30.06.2024
- Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
- Key Figures 15.06.2024
- Key Figures 31.05.2024
- HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
- HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
- Key Figures 15.05.2024
- HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
- Key Figures 30.04.2024
- Key Figures 15.04.2024
More ▼
Key statistics
On Friday, HBM Healthcare Investments AG (HBMN:SWX) closed at 198.40, -7.29% below its 52-week high of 214.00, set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 6.96m |
---|---|
Market cap | 1.40bn CHF |
Total assets | 1.75bn CHF |
Total expense ratio | 0.15% |
High | 202.50 |
Low | 196.00 |
Previous close | 201.00 |
Average volume | 4.05k |
---|---|
YTD Change | +8.65% |
Beta | 1.0322 |
Diluted NAV (est) | 252.07 |
Diluted NAV (last pub) | 252.07 |
Premium/Discount | -- |
Net Gearing | 0.00% |
Annual div (ADY) | 7.50 CHF |
---|---|
Annual div yield (ADY) | 3.78% |
Div ex-date | Aug 03 2023 |
Div pay-date | Aug 07 2023 |
Next div ex-date | Aug 07 2024 |
Next div pay-date | Aug 09 2024 |
Data delayed at least 15 minutes, as of Jul 05 2024 16:31 BST.
More ▼